These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 16516826

  • 1. Open-label pilot study of testosterone patch therapy in men with opioid-induced androgen deficiency.
    Daniell HW, Lentz R, Mazer NA.
    J Pain; 2006 Mar; 7(3):200-10. PubMed ID: 16516826
    [Abstract] [Full Text] [Related]

  • 2. Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men.
    Swerdloff RS, Wang C, Cunningham G, Dobs A, Iranmanesh A, Matsumoto AM, Snyder PJ, Weber T, Longstreth J, Berman N.
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4500-10. PubMed ID: 11134099
    [Abstract] [Full Text] [Related]

  • 3. Opioid-induced androgen deficiency (OPIAD).
    Smith HS, Elliott JA.
    Pain Physician; 2012 Jul; 15(3 Suppl):ES145-56. PubMed ID: 22786453
    [Abstract] [Full Text] [Related]

  • 4. Opioid endocrinopathy in women consuming prescribed sustained-action opioids for control of nonmalignant pain.
    Daniell HW.
    J Pain; 2008 Jan; 9(1):28-36. PubMed ID: 17936076
    [Abstract] [Full Text] [Related]

  • 5. Endocrine consequences of long-term intrathecal administration of opioids.
    Abs R, Verhelst J, Maeyaert J, Van Buyten JP, Opsomer F, Adriaensen H, Verlooy J, Van Havenbergh T, Smet M, Van Acker K.
    J Clin Endocrinol Metab; 2000 Jun; 85(6):2215-22. PubMed ID: 10852454
    [Abstract] [Full Text] [Related]

  • 6. Enhanced transdermal delivery of testosterone across nonscrotal skin produces physiological concentrations of testosterone and its metabolites in hypogonadal men.
    Meikle AW, Mazer NA, Moellmer JF, Stringham JD, Tolman KG, Sanders SW, Odell WD.
    J Clin Endocrinol Metab; 1992 Mar; 74(3):623-8. PubMed ID: 1740497
    [Abstract] [Full Text] [Related]

  • 7. Elucidating risk factors for androgen deficiency associated with daily opioid use.
    Rubinstein A, Carpenter DM.
    Am J Med; 2014 Dec; 127(12):1195-201. PubMed ID: 25063648
    [Abstract] [Full Text] [Related]

  • 8. Effects of testosterone replacement in men with opioid-induced androgen deficiency: a randomized controlled trial.
    Basaria S, Travison TG, Alford D, Knapp PE, Teeter K, Cahalan C, Eder R, Lakshman K, Bachman E, Mensing G, Martel MO, Le D, Stroh H, Bhasin S, Wasan AD, Edwards RR.
    Pain; 2015 Feb; 156(2):280-288. PubMed ID: 25599449
    [Abstract] [Full Text] [Related]

  • 9. A randomized, double-blind, placebo-controlled trial on the effect of long-acting testosterone treatment as assessed by the Aging Male Symptoms scale.
    Ho CC, Tong SF, Low WY, Ng CJ, Khoo EM, Lee VK, Zainuddin ZM, Tan HM.
    BJU Int; 2012 Jul; 110(2):260-5. PubMed ID: 22093057
    [Abstract] [Full Text] [Related]

  • 10. The relationship of salivary testosterone and male sexual dysfunction in opioid-associated androgen deficiency (OPIAD).
    Ajo R, Segura A, Mira L, Inda MD, Alfayate R, Sánchez-Barbie A, Margarit C, Peiró AM.
    Aging Male; 2017 Mar; 20(1):1-8. PubMed ID: 27750480
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of the 2% formulation of testosterone topical solution applied to the axillae in androgen-deficient men.
    Wang C, Ilani N, Arver S, McLachlan RI, Soulis T, Watkinson A.
    Clin Endocrinol (Oxf); 2011 Dec; 75(6):836-43. PubMed ID: 21689131
    [Abstract] [Full Text] [Related]

  • 12. Testosterone therapy in men with Parkinson disease: results of the TEST-PD Study.
    Okun MS, Fernandez HH, Rodriguez RL, Romrell J, Suelter M, Munson S, Louis ED, Mulligan T, Foster PS, Shenal BV, Armaghani SJ, Jacobson C, Wu S, Crucian G.
    Arch Neurol; 2006 May; 63(5):729-35. PubMed ID: 16682542
    [Abstract] [Full Text] [Related]

  • 13. Testosterone substitution normalizes elevated serum leptin levels in hypogonadal men.
    Jockenhövel F, Blum WF, Vogel E, Englaro P, Müller-Wieland D, Reinwein D, Rascher W, Krone W.
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2510-3. PubMed ID: 9253326
    [Abstract] [Full Text] [Related]

  • 14. Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study.
    Shifren JL, Davis SR, Moreau M, Waldbaum A, Bouchard C, DeRogatis L, Derzko C, Bearnson P, Kakos N, O'Neill S, Levine S, Wekselman K, Buch A, Rodenberg C, Kroll R.
    Menopause; 2006 Aug; 13(5):770-9. PubMed ID: 16932240
    [Abstract] [Full Text] [Related]

  • 15. Effect of 12 month oral testosterone on testosterone deficiency symptoms in symptomatic elderly males with low-normal gonadal status.
    Haren M, Chapman I, Coates P, Morley J, Wittert G.
    Age Ageing; 2005 Mar; 34(2):125-30. PubMed ID: 15596419
    [Abstract] [Full Text] [Related]

  • 16. Transdermal testosterone gel increases serum testosterone levels in hypogonadal men in Taiwan with improvements in sexual function.
    Chiang HS, Hwang TI, Hsui YS, Lin YC, Chen HE, Chen GC, Liao CH.
    Int J Impot Res; 2007 Mar; 19(4):411-7. PubMed ID: 17538639
    [Abstract] [Full Text] [Related]

  • 17. Transdermal testosterone administration in women with acquired immunodeficiency syndrome wasting: a pilot study.
    Miller K, Corcoran C, Armstrong C, Caramelli K, Anderson E, Cotton D, Basgoz N, Hirschhorn L, Tuomala R, Schoenfeld D, Daugherty C, Mazer N, Grinspoon S.
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2717-25. PubMed ID: 9709937
    [Abstract] [Full Text] [Related]

  • 18. Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study.
    Landau CJ, Carr WD, Razzetti AJ, Sessler NE, Munera C, Ripa SR.
    Clin Ther; 2007 Oct; 29(10):2179-93. PubMed ID: 18042474
    [Abstract] [Full Text] [Related]

  • 19. Androgen deficiency in long-term intrathecal opioid administration.
    Kim CH, Garcia R, Stover J, Ritchie K, Whealton T, Ata MA.
    Pain Physician; 2014 Oct; 17(4):E543-8. PubMed ID: 25054405
    [Abstract] [Full Text] [Related]

  • 20. A pharmacokinetic study of injectable testosterone undecanoate in hypogonadal men.
    Zhang GY, Gu YQ, Wang XH, Cui YG, Bremner WJ.
    J Androl; 1998 Oct; 19(6):761-8. PubMed ID: 9876028
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.